AbbVie cuts FY26 adjusted EPS view to $13.91-$14.11 from $14.08-$14.28

Consensus $14.25. AbbVie's full-year 2026 adjusted diluted earnings per share guidance range, including the impact of second-quarter 2026 acquired IPR&D and milestones expense, is $13.91 - $14.11. AbbVie's second-quarter 2026 adjusted diluted earnings per share guidance range, including the impact of second-quarter 2026 acquired IPR&D and milestones expense, is $3.57 - $3.61.